Actym Therapeutics
Phase 1Actym Therapeutics is deploying its biologically brilliant bacteria drug delivery platform to treat cancer with powerful immunotherapies. We are advancing our bacteria delivery system for cancer immunotherapy in a phase 1 clinical trial for solid tumors.
Founded
2016
Focus
Microbiome
About
Actym Therapeutics is deploying its biologically brilliant bacteria drug delivery platform to treat cancer with powerful immunotherapies. We are advancing our bacteria delivery system for cancer immunotherapy in a phase 1 clinical trial for solid tumors.
Funding History
4Total raised: $55M
Series A$25MRiverVest Venture PartnersOct 15, 2022
Seed$5MKdT VenturesMar 15, 2021
Series A$20MBoehringer Ingelheim Venture FundJun 15, 2020
Seed$5MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2016
LocationBerkeley, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile